Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2021 2
2022 1
2023 3
2024 6
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C; Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup. Tarvin SE, et al. Among authors: sabbagh se. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539. doi: 10.1002/acr.25393. Epub 2024 Aug 14. Arthritis Care Res (Hoboken). 2024. PMID: 38937134
Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype.
Neely J, Sabbagh SE, Dvergsten J, Madubata C, Berthier CC, Zheng Z, Goudsmit C, Matossian S, Ferris SP, Fragiadakis GK, Sirota M, Kahlenberg JM, Kim H, Turnier JL; CARRA Registry Investigators and CARRA Translational Medicine for Juvenile Myositis Working Group. Neely J, et al. Among authors: sabbagh se. Ann Rheum Dis. 2025 Sep 6:S0003-4967(25)04291-8. doi: 10.1016/j.ard.2025.07.020. Online ahead of print. Ann Rheum Dis. 2025. PMID: 40915939 Free article.
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh SE, O'Hanlon TP, Noroozi-Farhadi P, Targoff IN, Flegel WA, Mammen AL, Miller FW, Hicar MD, Rider LG, Jarvis JN. Karasawa R, et al. Among authors: sabbagh se. Rheumatology (Oxford). 2022 Jul 6;61(7):2969-2977. doi: 10.1093/rheumatology/keab846. Rheumatology (Oxford). 2022. PMID: 34791087 Free PMC article.
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL; Childhood Myositis Heterogeneity Collaborative Study Group. Sherman MA, et al. Among authors: sabbagh se. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI226-SI234. doi: 10.1093/rheumatology/keac428. Rheumatology (Oxford). 2023. PMID: 35961028 Free PMC article.
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
Sabbagh SE, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, Roberts J, Rouster-Stevens K, Schmeling H, Sura A, Tarshish G, Tucker L, Rider LG, Kim S; CARRA JDM Workgroup and the Childhood Myositis Heterogeneity Study Group. Sabbagh SE, et al. Rheumatology (Oxford). 2021 Feb 1;60(2):829-836. doi: 10.1093/rheumatology/keaa436. Rheumatology (Oxford). 2021. PMID: 32889531 Free PMC article.
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis.
Sherman MA, Yang Q, Gutierrez-Alamillo L, Pak K, Flegel WA, Mammen AL, Rider LG, Casciola-Rosen LA; Childhood Myositis Heterogeneity Collaborative Study Group. Sherman MA, et al. Arthritis Rheumatol. 2024 Apr;76(4):631-637. doi: 10.1002/art.42768. Epub 2024 Jan 30. Arthritis Rheumatol. 2024. PMID: 38059274 Free PMC article.
16 results